Drug details
Fluad (influenza virus vaccine, surface antigen, inactivated, adjuvanted with mf59c.1)
type of Vaccines, Inactivated, Viral
Fluad (influenza virus vaccine, surface antigen, inactivated, adjuvanted with MF59C.1) is a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), approved for the prevention of seasonal influenza in people 65 years of age and older. Fluad Pediatric is intended for use in the pediatric population of 6 months to less than 2 years of age.
This drug may have the following side effects:
- nausea,
- rash,
- diarrhea,
- fever,
- chills,
- joint pain,
- headache,
- fatigue,
- sweating,
- vomiting, and
- muscle pain,
- general feeling of being unwell (malaise),
- changes in appetite.
The following drugs are related to Fluad, either as a replacement or used together:
- Afluria (influenza virus vaccine)
- Afluria Quadrivalent 2020 (2020 influenza vaccine suspension for intramuscular injection)
- Xofluza (baloxavir marboxil)
- Zonatuss (benzonatate capsules, usp 150 mg)
- Vaxelis (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, haemophilus b conjugate [meningococcal protein conjugate] and hepatitis b [recombinant] vaccine)
- Fluarix Quadrivalent 2018-2019 (influenza vaccine)
- Flublok Quadrivalent 2018-2019 (influenza vaccine)
- Flublok Quadrivalent 2020-2021 (influenza vaccine)
- Flucelvax Quadrivalent 2018-2019 Formula (influenza vaccine)
- Flulaval (influenza virus vaccine)
- Flumadine (rimantadine)
- FluMist (influenza virus vaccine)
- FluMist 2018-2019 Formula (influenza vaccine intranasal)
- Fluzone (influenza virus vaccine)
- Influenza A H1N1 Intranasal Vaccine (influenza a h1n1 monovalent intranasal vaccine live)
- Influenza A H1N1 Monovalent Vaccine (influenza a h1n1 monovalent vaccine)
- Tamiflu (oseltamivir phosphate)
- Relenza (zanamivir)